Fangyan Gao

发表

Checkpoint inhibitor pneumonitis in Chinese lung cancer patients: clinical characteristics and risk factors.

R. Guo, Chen Zhang, Shidai Jin, 2020, Annals of palliative medicine.

Efficacy and acquired resistance of EGFR-TKI combined with chemotherapy as first-line treatment for Chinese patients with advanced non-small cell lung cancer in a real-world setting

R. Guo, Chen Zhang, Shidai Jin, 2020, BMC Cancer.

c-MYC mediates the crosstalk between breast cancer cells and tumor microenvironment

Kun Xu, Xintong Li, Runtian Wang, 2023, Cell Communication and Signaling.

Microenvironment components and spatially resolved single-cell transcriptome atlas of breast cancer metastatic axillary lymph nodes

Kun Xu, X. Guan, Hui Xie, 2022, Acta biochimica et biophysica Sinica.

Single-cell RNA sequencing reveals cell heterogeneity and transcriptome profile of breast cancer lymph node metastasis

Kun Xu, Y. Shu, X. Guan, 2021, Oncogenesis.

RNA methyltransferase METTL3 induces intrinsic resistance to gefitinib by combining with MET to regulate PI3K/AKT pathway in lung adenocarcinoma

R. Guo, Chen Zhang, Jifu Wei, 2021, Journal of cellular and molecular medicine.

Clinical considerations of CDK4/6 inhibitors in triple-negative breast cancer.

Kun Xu, X. Guan, Runtian Wang, 2021, Biochimica et biophysica acta. Reviews on cancer.

c-Myc-Targeting PROTAC Based on a TNA-DNA Bivalent Binder for Combination Therapy of Triple-Negative Breast Cancer.

Kun Xu, Feng Xu, Yuxuan Ma, 2023, Journal of the American Chemical Society.

E cacy and Acquired Resistance of EGFR-TKI Combined with Chemotherapy as First-Line Treatment for Chinese Patients with Advanced Non- Small Cell Lung Cancer in a Real-world Setting

Qian-Qian Wang, Fangyan Gao, Zhihong Zhang, 2020 .

Inhibition of MYC suppresses programmed cell death ligand-1 expression and enhances immunotherapy in triple-negative breast cancer

Kun Xu, X. Guan, Xintong Li, 2022, Chinese medical journal.

Precise nano-system-based drug delivery and synergistic therapy against androgen receptor-positive triple-negative breast cancer

Runtian Wang, Xin Han, Fangyan Gao, 2024, Acta pharmaceutica Sinica. B.